Healthcare Realty Trust Inc. (HR) reported first‑quarter 2026 revenue of $278.99 million, a 6.6% decline from the $298.98 million earned in the same period a year earlier. The decline reflects a modest contraction in the broader medical‑outpatient‑building market, but the company’s normalized funds from operations (FFO) per share rose to $0.41, up 5.13% from $0.39 in Q1 2025. The $0.41 figure beat the consensus estimate of a $0.0371 loss, a surprise of $0.4471 per share, driven largely by disciplined cost management and a 6.9% increase in same‑store cash net operating income (NOI).
Leasing activity in the quarter was robust: 291 new and renewal leases covering 2.0 million square feet were signed, with a weighted‑average lease term of 7.7 years and average annual escalators of 3.1%. The strong leasing performance is a result of sustained demand for medical outpatient buildings, the company’s focus on high‑quality tenant mix, and the completion of two redevelopment projects that expanded the portfolio’s value proposition. These new leases reinforce the company’s position as the nation’s largest pure‑play owner of medical outpatient buildings.
Capital allocation remained concentrated on the core portfolio, with $125 million of transaction activity that included two new redevelopment projects and the completion of one redevelopment. The company’s strategic capital allocation, including a joint venture with KKR, is designed to enhance asset quality and generate long‑term cash‑flow upside. The focus on redevelopment aligns with the company’s broader strategy to upgrade and reposition properties to capture higher operating income.
Management raised its full‑year 2026 normalized FFO guidance to $1.59–$1.65 per share, an increase of $0.01 at the midpoint, and lifted same‑store cash NOI growth guidance to 3.75%–4.75%. The guidance revision reflects confidence in continued demand for outpatient facilities, the effectiveness of the overhauled operating platform, and the anticipated impact of the new redevelopment projects. The company’s net debt to adjusted EBITDA ratio of 5.5× as of March 31 2026 indicates a healthy balance sheet that supports the guidance outlook.
The board declared a $0.24 per share dividend to be paid on May 22 2026 and announced the retirement of longtime director Jay Leupp. While the dividend and board change are routine, they underscore the company’s commitment to returning value to shareholders and maintaining a strong governance framework.
The company’s Q1 results and guidance raise signal a continued operational turnaround, with record leasing activity and higher-than‑expected earnings. The combination of a revenue miss against analyst expectations and a strong FFO beat illustrates the company’s ability to manage costs and capitalize on market tailwinds, positioning it for sustained growth in the medical‑outpatient‑building sector.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.